Log In Sign up
The largest database of trusted experimental protocols

Bv711 clone a019d5

Manufactured by BioLegend
Visit Supplier

BV711 (clone A019D5) is a fluorescent dye used in flow cytometry applications. It is designed to emit light in the BV711 range of the spectrum.

Automatically generated - may contain errors

Lab products found in correlation

Rhil 7, by Thermo Fisher Scientific (2 mentions) Rpa t4, by Thermo Fisher Scientific (2 mentions) Fitc conjugated cd127 ebiordr5, by Thermo Fisher Scientific (2 mentions) Bv421 conjugated, by BioLegend (2 mentions) Pe cy7 conjugated foxp3 pch101, by Thermo Fisher Scientific (2 mentions) V450 conjugated active caspase3 c92 605, by BD (2 mentions) Pe conjugated p y705 stat3 4 p stat3, by BD (2 mentions) Pe conjugated p y694 stat5 47 stat5, by BD (2 mentions) Pe conjugated ctla 4 14d3, by Thermo Fisher Scientific (2 mentions) Rhil 6, by BD (2 mentions) Rhil 15, by Thermo Fisher Scientific (2 mentions) Interleukin 6 (il 6), by Thermo Fisher Scientific (2 mentions) Cycloheximide (chx), by Merck Group (2 mentions) Recombinant human il rhil 2, by Thermo Fisher Scientific (1 mentions)

2 protocols using bv711 clone a019d5

1

Flow Cytometry Analysis of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following directly conjugated Abs were used in flow cytometry: BV711 or FITC-conjugated CD4 [OKT4 (Biolegend) or RPA-T4 (eBioscience)], BV711- (clone A019D5; Biolegend) or FITC-conjugated CD127 (eBioRDR5; eBioscience), PE- (BD Biosciences) or BV421-conjugated (Biolegend) CD25 (MA251), allophycocyanin-conjugated FOXP3 (236A/E7; eBioscience) or PE-Cy7–conjugated FOXP3 (PCH101; eBioscience), V450-conjugated active CASPASE3 (C92-605; BD Biosciences), PE-conjugated p-(Y705)STAT3 (4/P-STAT3; BD Biosciences), PE-conjugated p-(Y694)STAT5 (47/STAT5; BD Biosciences), PE-conjugated CTLA-4 (14D3; eBioscience). Recombinant human IL (rhIL)-2 (Roche), IL-6, rhIL-7, rhIL-15 (Peprotech), and rhIL-6 (BD Biosciences) were used at the concentrations indicated in the figure legends. Tocilizumab (TOC; anti–IL-6R) and infliximab (anti–TNF-α) were used at a final concentration of 10 μg/ml. Cycloheximide (Sigma) was used at a concentration of 50 μg/ml.
Bending D., Giannakopoulou E., Lom H, & Wedderburn L.R. (2015). Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein Expression. The Journal of Immunology Author Choice, 195(12), 5616-5624.
+ Open protocol
+ Expand
2

Flow Cytometry-Based Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following directly conjugated antibodies were used in flow cytometry: BV711 or FITC-conjugated CD4 (OKT4 (Biolegend) or RPA-T4 (eBioscience)), BV711- (clone A019D5, Biolegend) or FITC-conjugated CD127 (eBioRDR5, eBioscience), PE- (BD Biosciences) or BV421-conjugated (Biolegend) CD25 (MA251), APC-conjugated FOXP3 (236A/E7, eBioscience) or PE-Cy7-conjugated FOXP3 (PCH101, eBioscience), V450-conjugated active CASPASE3 (C92-605, BD Biosciences), PE-conjugated p-(Y705)STAT3 (4/P-STAT3, BD Biosciences), PE-conjugated p-(Y694)STAT5 (47/STAT5, BD Biosciences), PE-conjugated CTLA-4 (14D3, eBioscience). Recombinant human (rh) IL-2 (Roche), IL-6, rhIL-7, rhIL-15 (Peprotech) and rhIL-6 (BD Biosciences) were used at the concentrations indicated in the figure legends. Tocilizumab (anti-IL-6R) and Infliximab (anti-TNFα) were used at a final concentration of 10μg/ml. Cycloheximide (Sigma) was used at a concentration of 50μg/ml.
Bending D., Giannakopoulou E., Lom H, & Wedderburn L.R. (2015). Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein Expression. The Journal of Immunology Author Choice, 195(12), 5616-5624.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!